![]() |
|
searchpremium serviceseventsdirectory servicesadvertisingcustomer care |
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients Contract Fine Chemicals: Hindsight9:50 AM MDT | March 15, 2010 | Guy Villax CEO of Hovione For most of this decade we have been told that the number of new drug approvals by FDA is decreasing. An article published in Nature in December 20091 sheds new light on this. Bernard Munos researched the last 60 years of drug approvals. 1222 NME were approved by FDA since 1958 – and its conclusions are startling: 1. There was no reduction of NME approvals since the Nineties, instead what occurred in the 2nd half of the 90s was an unusually large number of approvals. One more reason for the flood of... This information is only available to Chemical Week subscribers. Forgot your user ID or password?
|
Not an IHS Chemical Week
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|